The Guild
Advertisement

Third Agreement R&D

It was the goal of the Third Community Pharmacy Agreement R&D Program to identify research priority areas in community pharmacy service provision and to then fund projects with the greatest potential to deliver services with positive health and economic impacts to consumers and the health system.

The Pharmacy Guild of Australia developed research priorities for the program through an extensive consultation process with stakeholders and communication with the Department of Health and Ageing. The priorities allowed the Guild and associated stakeholders to focus the funding to areas of most importance.  This allowed a large number and impressive variety of high quality projects to be funded through the program.

As an example, the priority areas for 2003 included:

  • Quality use of medicines
  • Continuing care across the health system
  • Evaluation and further development of existing community pharmacy services and programs
  • Development of new cognitive services
  • Harm reduction for drug dependent people
  • Facilitating change processes within pharmacy practice and the health system to deliver higher quality and cost effective pharmacy professional services
  • Pharmacy workforce.

Funded Projects

This page provides a list of projects funded under the Third Agreement Research and Development Program. 

Project ID

Type of Grant

Title

Current Status

Chief Researcher

2005-522

Commissioned

Weight Management

Completed

Associate Professor Allan Everett

2005-501

Commissioned

Consumer Experiences, Needs and Expectations of Community Pharmacy

Completed

Dr Kathy Mott

2005-531

Commissioned

Consumer Access to Prescription Medicines

Completed

Wayne Kinrade

2005-532

Commissioned

Evaluation of the R&D Program

Completed

Professor Rosemary Calder

2001-008

Investigator Initiated

Woundcare benchmarking in community pharmacy - Piloting a QA indicator development

Completed

Dr Julie Stokes

2001-011

Investigator Initiated

Development and evaluation of a computerised system for the provision and documentation of community pharmacists' cognitive services

Completed

Professor Greg Peterson

2001-028

Investigator Initiated

Pharmacy and general practice disease management collaboration

Completed

Reitai Minogue

2001-036

Investigator Initiated

Community pharmacists providing clinical services for dispensing doctors and depot pharmacies in rural Queensland - tele-pharmacy

Unpublished

Dr Lisa Nissen

2001-041

Investigator Initiated

Educating community pharmacists to provide quality advice and information to consumers via the internet

Completed

Professor Chris Silagy

2001-049

Investigator Initiated

Enhancing the value of pharmacists through augmented competency standards and targeted professional practice standards

Completed

Bill Kelly

2001-052

Investigator Initiated

Mentor support program

Completed

Leone Coper

2001-054

Investigator Initiated

The economics of pharmaceutical services for methadone services in a public clinic and community pharmacies

Unpublished

Professor Bruce Sunderland

2001-055

Investigator Initiated

Hypertension: Improving patient compliance and clinical outcomes through community pharmacist managed care

Completed

Dr Jeffery Hughes

2001-056

Investigator Initiated

Reference data base of Australia's community pharmacies: analysis of national survey

Completed

Con Berbatis

2001-064

Investigator Initiated

Case conferences and care planning - Collaboration between community pharmacists and general practitioners

Completed

Dr Dr Tim Chen

2001-070

Investigator Initiated

An investigation into business and professional facilitators for change for the pharmacy profession in light of the Third Guild/Government Agreement

Completed

Professor Charlie Benrimoj

2001-072

Investigator Initiated

Professional pharmacy services to private hospitals

Completed

Rebekah Moles

2001-074

Investigator Initiated

Pharmacy Asthma Action Plan - Pharmacists receiving remuneration for addressing the issues for people with asthma in the community

Completed

Dr Sinthia Bosnic- Anticevich

2001-075

Investigator Initiated

An integrated model for disease state management (DSM) in diabetes: collaboration of the community pharmacist and GP in continuity of care

Completed

Associate Professor Ines Krass

2001-501

Commissioned

Pharmacy workforce supply and demand 2000-2010

Completed

Dr David Gadiel

2001-502

Commissioned

Cost benefit analysis of pharmacist only and pharmacy medicines and a risk based evaluation of the standards

Completed

Professor Charlie Benrimoj

2002-004

Investigator Initiated

Ensuring the appropriateness of topical over-the-counter antifungal agents for clients with self-diagnosed vaginal thrush

Completed

Peter Tenni

2002-005

Investigator Initiated

Customised education programs for patients with Diabetes Mellitus - Use of Structured Questionnaires and Education Modules

Completed

Jeffery Hughes

2002-009

Investigator Initiated

Rural community pharmacists integrating care for people with complex health needs

Completed

Dr Lisa Nissen

2002-013

Investigator Initiated

Improving the quality, effectiveness and sustainability of smoking cessation services, delivered through community pharmacies

Completed

Professor Andrew Gilbert

2002-020

Investigator Initiated

Developing a sustainable Pharmacy Support Network to address geographical issues associated with quality use of medicines

Completed

Fiona Kelly

2002-022

Investigator Initiated

Pharmacy-based program to tackle coronary heart disease in the Australian community.

Completed

Professor Greg Peterson

2002-024

Investigator Initiated

A community pharmacist delivered therapeutics outcome monitoring service for hyperlipidemia

Completed

Dr Parisa Aslani

2002-026

Investigator Initiated

An integrated service, initiated by community pharmacists, for the prevention of osteoporosis

Completed

Dr Susan Taylor

2002-027

Investigator Initiated

A community pharmacy based anticoagulant management service

Completed

Dr Andrew McLachlan

2002-028

Investigator Initiated

From hospital to community: a multidisplinary "continuity of care" model for cardiovascular patients involving community pharmacists

Completed

Dr Tim Chen

2002-504

Commissioned

Review of DMMR software

Completed

Wayne Kinrade

2002-507

Commissioned

The value of pharmacist professional services in the community setting

Completed

Dr Libby Roughhead

2002-508

Commissioned

Community Pharmacy Research Support Centre

Completed

Professor Carol Armour

2002-516

Commissioned

Workforce and career path options for pharmacy assistants

Completed

Wayne Kinrade

2002-518

Commissioned

Pharmacy Diabetes Care Program

Completed

Associate Professor Ines Krass

2002-519

Commissioned

Effectiveness and cost effectiveness of Dose Administration Aids

Completed

Professor Michael Roberts

2003-005

Investigator Initiated

Improving medication management of palliative care patients: enhancing the role of community pharmacists

Completed

Professor Roger Nation

2003-007

Investigator Initiated

Quantification of facilitators to accelerate uptake of cognitive pharmaceutical services (CPS) in community pharmacy

Completed

Professor Charlie Benrimoj

2003-008

Investigator Initiated

Asthma self-management in the community: pharmacists facilitating empowerment of patient asthma self-management practices through collaboration

Completed

Dr Sinthia Bosnic- Anticevich

2003-010

Investigator Initiated

3D* Labels (Dandenong Division of General Practice)

Completed

Graeme Sweet

2003-013

Investigator Initiated

Medication management and education of osteoarthritis patients: evaluation of a role for community pharmacists

Completed

Dr Tim Chen

2003-017

Investigator Initiated

Improving Australian's access to prescription medicines: Development of pharmacy practice models

Completed

Dr Tracey Bessell

2003-028

Investigator Initiated

Collaboration between CP & mental health care practitioners

Completed

Dr Paula Whitehead

2003-504

Commissioned

Community Pharmacy Medication Incident and Reporting Management System (CPMIRMS) (PROMISe)

Completed

Professor Greg Peterson

2003-519

Commissioned

Evaluation of Clinical Interventions within Community Pharmacy (PROMISe II)

Completed

Professor Greg Peterson

2003-524

Commissioned

Facilitating quality use of medicines between hospital and community (Med-E-Support)

Completed

Professor Greg Peterson

2003-526

Commissioned

Pharmacy Asthma Care Program

Completed

Professor Carol Armour

2003-530

Commissioned

Change management and community pharmacy

Completed

Distinguished Professor Dexter Dunphy

2004-503

Commissioned

The role of pharmacy in immunisation

Completed

Professor Joan Dawes

2004-509

Commissioned

Pharmacy Continence Care Program

Completed

Professor Rosemary Calder

2004-511

Commissioned

Pharmacy Cardiovascular Health Care Model

Completed

Professor Greg Peterson

2004-526

Commissioned

Evaluation of HMR Program

Completed

John Schwartzkoff

2004-532

Commissioned

Development, Implementation and Evaluation of Funding Model Options for the Dispensing of Pharmacotherapies for Opioid Dependence in Community Pharmacy (Addiction Care 1)

Completed

Wayne Kinrade

2004-534

Commissioned

Dispensing and Monitoring of Schedule 8 and Schedule 4 (with dependency properties) Drugs (Addiction Care 2)

Completed

Chris Lynton-Moll

2004-536

Commissioned

Effectiveness and cost effectiveness of Dose Administration Aids - phase 3 (DAA phase 3)

Completed

Professor Michael Roberts

92001-01

Commissioned

Evaluation of the Quality Care Pharmacy Program

Completed

John Chapman

92002-04

Commissioned

Evaluation of the Medicine Information for consumers (MIC) program

Completed

Murray Benton

The Pharmacy Guild of Australia has made every effort to ensure that, at the date of publication, the documents are free from error and that advice and information drawn upon have been provided in good faith. Neither The Pharmacy Guild of Australia nor any person or organisation associated with the preparation of these documents accepts liability for any loss which a user of these documents may suffer as a result of reliance on these documents and in particular:

  • Use of the documents for a purpose for which they were intended;
  • Any errors or omissions in the documents;
  • Any inaccuracies in the information or data on which the documents are based or which are contained in the documents; or
  • Any interpretation or opinions stated in, or which may be inferred from, the documents.